John M. Zahradnik

A Vaccine Consisting of Recombinant<i>Borrelia burgdorferi</i>Outer-Surface Protein A to Prevent Lyme Disease

Leonard H. Sigal, John M. Zahradnik, Philip T. Lavin et al. · New England Journal of Medicine · 1998 · 394 citations · Full text

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

Niranjan Kanesa-thasan, Wellington Sun, Gina Kim-Ahn et al. · Vaccine · 2001 · 218 citations

Vaccination, Vaccine Development, Human Volunteers +6

Adenovirus infection in the immunocompromised patient

John M. Zahradnik, Mary Jo Spencer, David Porter · The American Journal of Medicine · 1980 · 214 citations

Diagnostic Virology, Adenovirus Infection, Viral Persistence +3

Influenza: Its Control in Persons and Populations

R. B. Couch, J. A. Kasel, W. Paul Glezen et al. · The Journal of Infectious Diseases · 1986 · 173 citations

Disease Outbreak, Many Influenza Epidemics, Flu Vaccination +19

A Canarypox Vector–Expressing Cytomegalovirus (CMV) Phosphoprotein 65 Induces Long‐Lasting Cytotoxic T Cell Responses in Human CMV‐Seronegative Subjects

Klára Berencsi, Zsófia Gyulai, Éva Gönczöl et al. · The Journal of Infectious Diseases · 2001 · 146 citations · Full text